LABATE ed altri: "Nuove norme in materia di informazione e di pubblicità sui medicinali ad uso umano" (5224)

This procedure concerns new rules for providing information and advertising about medicines intended for human use. It aims to ensure clarity and accuracy in how these medicines are presented to the public and healthcare professionals. The changes will affect pharmaceutical companies, healthcare providers, and ultimately patients, by standardizing the information and advertising practices related to medicinal products.